Earnings presentations and investor-related webinars

Proactive Investor Interview: Marrone Bio Innovations signs deal to collaborate with Compass Minerals Plant Nutrition

Marrone Bio Innovations (Nasdaq:MBII) CEO DR Pamela Marrone joined Steve Darling from Proactive Investors in our New York studio to talk about a deal Compass Minerals Plant Nutrition.

National Securities Initiates Coverage of MBII

Download the report: MBII Initiation, National Securities January 23, 2019 Marrone Bio Innovations BUY (MBII, $1.31) Bucking The Trend: Buy Opportunity For High Growth Business In Sluggish…

MBI Investor Alert: Agriculture Improvement Act of 2018

Investor Alert: The Agriculture Improvement Act of 2018, better known as the 2018 Farm Bill, holds numerous potential advantages for Marrone Bio Innovations (NASDAQ: MBII) (MBI). The bill’s…

Marrone Bio Innovations sets record in Q-3 financials

Marrone Bio Innovations (MBII-NASDAQ) CEO Marrone joined Steve Darling from Proactive Investors at the LD Micro Show in Los Angeles to talk about the success her company has seen especially in Q-3.…

Update with Marrone Bio Innovations, Inc. (NASDAQ: MBII) – | Stock News Now

SNNLive spoke with Dr. Pamela Marrone, Founder and CEO of Marrone Bio Innovations, Inc. (NASDAQ: MBII) at the LD Micro "Main Event" 2018 in Bel Air, CA.